Data / Form D filings / Gladius Therapeutics, Inc.
Gladius Therapeutics, Inc.: Form D filing
Gladius Therapeutics, Inc., a health care company in Philadelphia, PA, filed a Form D with the SEC in 2023. The latest, on August 22, 2023, reports $300,000 sold of a $300,000 offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- B+LABS, FLOOR 2, 2929 ARCH STREET, Philadelphia, PA, 19104
- Phone
- (215) 518-3590
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1986426
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 22, 2023 | New notice | $300,000 | $300,000 | 4 | Aug 14, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Seiden | Executive Officer, Director, Promoter |
Other health care companies in Pennsylvania that filed recently
- Septal Solutions, Inc. $7.3 million · Oct 27, 2026
- Lungpacer Medical, Inc. $7.8 million · Oct 14, 2026
- Plowshare Holdings LLC $7.8 million · Oct 14, 2026
- Peca Labs, Inc. $12.8 million · Oct 9, 2026
- McAllen Digestive Surgery Center, LLC offering · Sep 30, 2026
- Toetal Solutions, Inc. $50,000 · Sep 24, 2026
Every Form D from the week of Aug 21, 2023 · All recent filings in Pennsylvania · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Gladius Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.